|By PR Newswire||
|August 27, 2014 07:30 AM EDT||
MONMOUTH JUNCTION, N.J., Aug. 27, 2014 /PRNewswire/ -- Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that it has been selected as an award winner in the New Jersey Business & Industry Association's 2014 Awards for Excellence competition in the Business Expansion category. Finalists were selected by an independent panel of judges from SCORE (Counselors to America's Small Business) and NJBIA member company volunteers. Award winners will be honored at a gala event to be held on October 15, 2014 at the Pines Manor in Edison, New Jersey.
The Business Expansion Award is presented to companies that have contributed to the state's economic growth through the expansion of their business. Tris was selected for its significant growth in the creation of new jobs over the past three years.
"We're thrilled to be an award winner for the NJBIA's 2014 Awards for Excellence competition" said President & CEO Ketan Mehta. "Tris has been part of the New Jersey landscape for 14 years and we believe in supporting the prosperity of our local communities; on behalf of myself and our employees I'd like to thank the community for their support and the Awards for Excellence Committee for selecting Tris to receive this award."
Tris has several proprietary solubilization and bioavailability enhancing technologies as well as several generic extended release solid dosage products in development, under FDA review and in the market. Tris' proprietary technologies and developed products are the catalyst for its' dramatic growth over the past three years culminating in a 24-hour operation and the addition of almost 250 jobs.
About Tris Pharma:
Tris Pharma is a specialty pharmaceutical company focused on the research and development of technologies-driven products. Tris has pioneered the delivery of sustained release in the liquid, chewable/ODT and strip dosage forms so patients do not have to swallow a pill. Tris' Nobuse™ technology provides abuse deterrence for opioids and other abuse-prone drugs. Tris' R&D and manufacturing facilities are located in Monmouth Junction, New Jersey, U.S.A. For more information, please visit http://www.trispharma.com
SOURCE Tris Pharma
SYS-CON Events announced today that Enzu will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Enzu’s mission is to be the leading provider of enterprise cloud solutions worldwide. Enzu enables online businesses to use its IT infrastructure to their competitive advantage. By offering a suite of proven hosting and management services, Enzu wants companies to focus on the core of their online busine...
Oct. 28, 2016 07:30 PM EDT Reads: 1,489
Oct. 28, 2016 07:15 PM EDT Reads: 671
Oct. 28, 2016 07:00 PM EDT Reads: 386
Oct. 28, 2016 07:00 PM EDT Reads: 4,243
Oct. 28, 2016 07:00 PM EDT Reads: 402
Oct. 28, 2016 06:30 PM EDT Reads: 376
Oct. 28, 2016 06:30 PM EDT Reads: 662
Oct. 28, 2016 06:15 PM EDT Reads: 2,939
Oct. 28, 2016 05:45 PM EDT Reads: 1,727
Oct. 28, 2016 05:30 PM EDT Reads: 319
Oct. 28, 2016 05:30 PM EDT Reads: 3,331
Oct. 28, 2016 04:45 PM EDT Reads: 328
Oct. 28, 2016 04:30 PM EDT Reads: 1,230
Oct. 28, 2016 04:30 PM EDT Reads: 780
Oct. 28, 2016 04:30 PM EDT Reads: 5,256